Zurich Insurance Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $157M | Sell |
170,467
-64,667
| -28% | -$65.6M | 1.23% | 9 |
|
|
2025
Q4 | $253M | Buy |
235,134
+60,576
| +35% | +$57.9M | 1.75% | 9 |
|
|
2025
Q3 | $133M | Sell |
174,558
-29,930
| -15% | -$22.3M | 0.95% | 22 |
|
|
2025
Q2 | $159M | Sell |
204,488
-21,045
| -9% | -$16.4M | 1.23% | 14 |
|
|
2025
Q1 | $186M | Buy |
225,533
+19,832
| +10% | +$16.5M | 1.51% | 8 |
|
|
2024
Q4 | $159M | Sell |
205,701
-6,532
| -3% | -$5.41M | 1.29% | 13 |
|
|
2024
Q3 | $188M | Sell |
212,233
-83,562
| -28% | -$75.1M | 1.59% | 10 |
|
|
2024
Q2 | $268M | Buy |
295,795
+60,897
| +26% | +$48.7M | 2.32% | 7 |
|
|
2024
Q1 | $183M | Buy |
234,898
+5,719
| +2% | +$4.07M | 1.67% | 9 |
|
|
2023
Q4 | $134M | Sell |
229,179
-34,068
| -13% | -$19.9M | 1.36% | 9 |
|
|
2023
Q3 | $141M | Sell |
263,247
-130,218
| -33% | -$67.1M | 1.5% | 13 |
|
|
2023
Q2 | $185M | Buy |
393,465
+145,277
| +59% | +$60.9M | 1.91% | 7 |
|
|
2023
Q1 | $85.2M | Buy |
248,188
+146,769
| +145% | +$49.5M | 1.07% | 22 |
|
|
2022
Q4 | $37.1M | Sell |
101,419
-105,516
| -51% | -$37.4M | 0.53% | 71 |
|
|
2022
Q3 | $66.9M | Sell |
206,935
-85,731
| -29% | -$27.2M | 1.04% | 32 |
|
|
2022
Q2 | $94.9M | Sell |
292,666
-112,850
| -28% | -$33.9M | 1.41% | 17 |
|
|
2022
Q1 | $116M | Buy |
+405,516
| New | +$104M | 1.44% | 13 |
|
|
2019
Q4 | – | Sell |
-150,898
| Closed | -$16.9M | – | 372 |
|
|
2019
Q3 | $16.9M | Sell |
150,898
-2,330
| -2% | -$259K | 0.32% | 75 |
|
|
2019
Q2 | $17M | Sell |
153,228
-67,388
| -31% | -$7.94M | 0.34% | 71 |
|
|
2019
Q1 | $28.6M | Buy |
220,616
+67,382
| +44% | +$8.19M | 0.61% | 38 |
|
|
2018
Q4 | $17.7M | Sell |
153,234
-19,540
| -11% | -$2.18M | 0.43% | 68 |
|
|
2018
Q3 | $18.5M | Buy |
172,774
+4,747
| +3% | +$475K | 0.39% | 70 |
|
|
2018
Q2 | $14.3M | Buy |
168,027
+13,145
| +8% | +$1.08M | 0.32% | 81 |
|
|
2018
Q1 | $12M | Sell |
154,882
-28,866
| -16% | -$2.32M | 0.28% | 93 |
|
|
2017
Q4 | $15.5M | Buy |
183,748
+29,526
| +19% | +$2.51M | 0.36% | 59 |
|
|
2017
Q3 | $13.2M | Buy |
154,222
+16,726
| +12% | +$1.37M | 0.36% | 63 |
|
|
2017
Q2 | $11.3M | Sell |
137,496
-13,243
| -9% | -$1.08M | 0.32% | 69 |
|
|
2017
Q1 | $12.7M | Buy |
150,739
+10,431
| +7% | +$835K | 0.37% | 60 |
|
|
2016
Q4 | $10.3M | Sell |
140,308
-21,398
| -13% | -$1.59M | 0.33% | 70 |
|
|
2016
Q3 | $13M | Buy |
161,706
+12,964
| +9% | +$1.04M | 0.44% | 52 |
|
|
2016
Q2 | $11.7M | Buy |
148,742
+19,377
| +15% | +$1.46M | 0.41% | 64 |
|
|
2016
Q1 | $9.32M | Sell |
129,365
-34,097
| -21% | -$2.58M | 0.33% | 76 |
|
|
2015
Q4 | $13.8M | Buy |
163,462
+21,779
| +15% | +$1.81M | 0.49% | 60 |
|
|
2015
Q3 | $11.9M | Buy |
+141,683
| New | +$12M | 0.44% | 85 |
|
Other funds holding LLY
VCM
VPM
Zurich Insurance Group's LLY Position: Q1 2026 in Review
Zurich Insurance Group reduced its Eli Lilly (LLY) stake by 28% in Q1 2026, selling an estimated $65.6M and leaving 170,467 shares worth $157M. The position accounts for 1.23% of the portfolio, ranked #9.
Zurich Insurance Group first reported a position in LLY in Q3 2015 and has held it in 34 quarters since. The position peaked at $268M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Zurich Insurance Group held 170,467 shares of Eli Lilly worth $157M as of Q1 2026.
- Zurich Insurance Group sold 64,667 Eli Lilly shares in Q1 2026, an estimated $65.6M.
- Eli Lilly made up 1.23% of Zurich Insurance Group's portfolio in Q1 2026, its #9 holding.
- Zurich Insurance Group first reported a position in Eli Lilly in Q3 2015 and has held it in 34 quarters since.
- Zurich Insurance Group's Eli Lilly position peaked at $268M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.